Reported about 18 hours ago
In October, investors seeking reliable dividend stocks may consider three pharmaceutical companies recommended by Motley Fool contributors: AbbVie, Amgen, and Pfizer. AbbVie boasts a remarkable 52 consecutive years of dividend increases and a forward yield of 3.15%. Amgen offers a 2.8% yield with a strong history of payout growth and a promising treatment in development. Pfizer, with an impressive forward yield of 5.91%, shows potential resilience despite challenges in COVID vaccine sales, backed by solid free cash flow. These stocks not only provide income but also growth potential.
Source: YAHOO